Blasts Under 10 Percent of Bone Marrow Nucleated Cells
1 clinical trials · Condition
◉ Watch Blasts Under 10 Percent of Bone Marrow Nucleated Cells
| Record | Firm | Date |
|---|---|---|
| Nivolumab in AML in Remission at High Risk for Relapse (NCT02532231) | M.D. Anderson Cancer Center | 2015-10-19 |
Track Blasts Under 10 Percent of Bone Marrow Nucleated Cells automatically
Every clearance here is in the API, with alerts when new ones post.